Literature DB >> 25935933

Quantitative analysis of vascular heterogeneity in breast lesions using contrast-enhanced 3-D harmonic and subharmonic ultrasound imaging.

Anush Sridharan, John R Eisenbrey, Priscilla Machado, Haydee Ojeda-Fournier, Annina Wilkes, Alexander Sevrukov, Robert F Mattrey, Kirk Wallace, Carl L Chalek, Kai E Thomenius, Flemming Forsberg.   

Abstract

Ability to visualize breast lesion vascularity and quantify the vascular heterogeneity using contrast-enhanced 3-D harmonic (HI) and subharmonic (SHI) ultrasound imaging was investigated in a clinical population. Patients (n = 134) identified with breast lesions on mammography were scanned using power Doppler imaging, contrast-enhanced 3-D HI, and 3-D SHI on a modified Logiq 9 scanner (GE Healthcare). A region of interest corresponding to ultrasound contrast agent flow was identified in 4D View (GE Medical Systems) and mapped to raw slice data to generate a map of time-intensity curves for the lesion volume. Time points corresponding to baseline, peak intensity, and washout of ultrasound contrast agent were identified and used to generate and compare vascular heterogeneity plots for malignant and benign lesions. Vascularity was observed with power Doppler imaging in 84 lesions (63 benign and 21 malignant). The 3-D HI showed flow in 8 lesions (5 benign and 3 malignant), whereas 3-D SHI visualized flow in 68 lesions (49 benign and 19 malignant). Analysis of vascular heterogeneity in the 3-D SHI volumes found benign lesions having a significant difference in vascularity between central and peripheral sections (1.71 ± 0.96 vs. 1.13 ± 0.79 dB, p < 0.001, respectively), whereas malignant lesions showed no difference (1.66 ± 1.39 vs. 1.24 ± 1.14 dB, p = 0.24), indicative of more vascular coverage. These preliminary results suggest quantitative evaluation of vascular heterogeneity in breast lesions using contrast-enhanced 3-D SHI is feasible and able to detect variations in vascularity between central and peripheral sections for benign and malignant lesions.

Entities:  

Mesh:

Year:  2015        PMID: 25935933      PMCID: PMC4607037          DOI: 10.1109/tuffc.2014.006886

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  31 in total

Review 1.  Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents.

Authors:  K W Ferrara; C R Merritt; P N Burns; F S Foster; R F Mattrey; S A Wickline
Journal:  Acad Radiol       Date:  2000-10       Impact factor: 3.173

2.  Quantitative vascularity of breast masses by Doppler imaging: regional variations and diagnostic implications.

Authors:  C M Sehgal; P H Arger; S E Rowling; E F Conant; C Reynolds; J A Patton
Journal:  J Ultrasound Med       Date:  2000-07       Impact factor: 2.153

3.  Diagnosis of breast cancer: contribution of US as an adjunct to mammography.

Authors:  H M Zonderland; E G Coerkamp; J Hermans; M J van de Vijver; A E van Voorthuisen
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

4.  Nondestructive subharmonic imaging.

Authors:  James Chomas; Paul Dayton; Donovan May; Katherine Ferrara
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2002-07       Impact factor: 2.725

5.  Diagnosing breast lesions with contrast-enhanced 3-dimensional power Doppler imaging.

Authors:  Flemming Forsberg; Barry B Goldberg; Christopher R B Merritt; Laurence Parker; Andrea J Maitino; Juan J Palazzo; Daniel A Merton; Susan M Schultz; Laurence Needleman
Journal:  J Ultrasound Med       Date:  2004-02       Impact factor: 2.153

6.  Subharmonic signal generation from contrast agents in simulated neovessels.

Authors:  Govind Bhagavatheeshwaran; William T Shi; Flemming Forsberg; P M Shankar
Journal:  Ultrasound Med Biol       Date:  2004-02       Impact factor: 2.998

7.  Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: initial results.

Authors:  M H Chaudhari; F Forsberg; A Voodarla; F N Saikali; S Goonewardene; L Needleman; G C Finkel; B B Goldberg
Journal:  Ultrasonics       Date:  2000-03       Impact factor: 2.890

8.  Differentiation between benign and malignant disease of the breast using digital subtraction angiography of the breast.

Authors:  A C Watt; L V Ackerman; P C Shetty; M Burke; M Flynn; C Grodsinsky; G Fine; S Wilderman
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

9.  Ultrasound as a complement to mammography and breast examination to characterize breast masses.

Authors:  Kenneth J W Taylor; Christopher Merritt; Catherine Piccoli; Robert Schmidt; Glenn Rouse; Bruno Fornage; Eva Rubin; Dianne Georgian-Smith; Fred Winsberg; Barry Goldberg; Ellen Mendelson
Journal:  Ultrasound Med Biol       Date:  2002-01       Impact factor: 2.998

10.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Authors:  N Weidner; J Folkman; F Pozza; P Bevilacqua; E N Allred; D H Moore; S Meli; G Gasparini
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

View more
  10 in total

1.  High and low frequency subharmonic imaging of angiogenesis in a murine breast cancer model.

Authors:  Manasi Dahibawkar; Mark A Forsberg; Aditi Gupta; Samantha Jaffe; Kelly Dulin; John R Eisenbrey; Valgerdur G Halldorsdottir; Anya I Forsberg; Jaydev K Dave; Andrew Marshall; Priscilla Machado; Traci B Fox; Ji-Bin Liu; Flemming Forsberg
Journal:  Ultrasonics       Date:  2015-05-05       Impact factor: 2.890

Review 2.  Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review.

Authors:  Rongrong Guo; Guolan Lu; Binjie Qin; Baowei Fei
Journal:  Ultrasound Med Biol       Date:  2017-10-26       Impact factor: 2.998

3.  Characterizing Breast Lesions Using Quantitative Parametric 3D Subharmonic Imaging: A Multicenter Study.

Authors:  Anush Sridharan; John R Eisenbrey; Maria Stanczak; Priscilla Machado; Daniel A Merton; Annina Wilkes; Alexander Sevrukov; Haydee Ojeda-Fournier; Robert F Mattrey; Kirk Wallace; Flemming Forsberg
Journal:  Acad Radiol       Date:  2019-12-16       Impact factor: 3.173

4.  Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.

Authors:  Kibo Nam; John R Eisenbrey; Maria Stanczak; Anush Sridharan; Adam C Berger; Tiffany Avery; Juan P Palazzo; Flemming Forsberg
Journal:  Radiology       Date:  2017-05-03       Impact factor: 11.105

5.  Subharmonic and Endoscopic Contrast Imaging of Pancreatic Masses: A Pilot Study.

Authors:  Flemming Forsberg; Maria Stanczak; Andrej Lyshchik; David Loren; Patrick O'Kane; Ali Siddiqui; Thomas E Kowalski; Cynthia Miller; Traci Fox; Ji-Bin Liu; John R Eisenbrey
Journal:  J Ultrasound Med       Date:  2017-07-06       Impact factor: 2.153

Review 6.  Quantitative Nonlinear Contrast-Enhanced Ultrasound of the Breast.

Authors:  Anush Sridharan; John R Eisenbrey; Jaydev K Dave; Flemming Forsberg
Journal:  AJR Am J Roentgenol       Date:  2016-05-25       Impact factor: 3.959

7.  First-in-Human Study of Acoustic Angiography in the Breast and Peripheral Vasculature.

Authors:  Sarah E Shelton; Brooks D Lindsey; Paul A Dayton; Yueh Z Lee
Journal:  Ultrasound Med Biol       Date:  2017-10-02       Impact factor: 2.998

8.  Comparing Quantitative Immunohistochemical Markers of Angiogenesis to Contrast-Enhanced Subharmonic Imaging.

Authors:  Aditi Gupta; Mark A Forsberg; Kelly Dulin; Samantha Jaffe; Jaydev K Dave; Valgerdur G Halldorsdottir; Andrew Marshall; Anya I Forsberg; John R Eisenbrey; Priscilla Machado; Traci B Fox; Ji-Bin Liu; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2016-07-07       Impact factor: 2.153

Review 9.  Current State of Breast Cancer Diagnosis, Treatment, and Theranostics.

Authors:  Arya Bhushan; Andrea Gonsalves; Jyothi U Menon
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

10.  Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.

Authors:  Ahmed El Kaffas; Rosa Maria Silveira Sigrist; George Fisher; Sunitha Bachawal; Joy Liau; Huaijun Wang; Alexander Karanany; Isabelle Durot; Jarrett Rosenberg; Dimitre Hristov; Jürgen K Willmann
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.